.png){kind=icon}
.png){kind=icon}
Return
Inflammatory bowel disease must be a policy priority after the 2025 United Nations declaration on non-communicable diseases and mental health
.png){kind=icon}
OA
AI
A
A
V
A
DOI：10.1093/ecco-jcc/jjag048.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
The 2025 United Nations Political Declaration on non-communicable diseases (NCDs) and mental health provides a critical opportunity to recognize inflammatory bowel disease (IBD) as part of the global NCD agenda. Once confined to the West, IBD now affects over 7 million people worldwide, with the steepest rise in South Asia, Latin America, and Africa. Its early onset, chronic relapsing course, psychosocial burden, and economic cost align it closely with major NCDs. Yet, policy recognition remains limited, particularly in low- and middle-income countries, where diagnostic delays, inequitable access to advanced therapies (biologics and small molecules), and catastrophic healthcare costs persist. Integrating IBD into national NCD frameworks, universal health coverage schemes, and essential drug lists would advance Sustainable Development Goals. The Declaration’s emphasis on mental health is especially relevant, as anxiety and depression affect nearly 40% of IBD patients, influencing disease activity and outcomes. Embedding psychosocial care, primary care training, and research equity into IBD programs will foster patient-centered, resilient health systems. Recognizing IBD within the NCD continuum is both a moral and policy imperative, essential to achieving equitable, integrated, and sustainable chronic disease care in the 21st century.
Journal
IF:
8.7
Papers:
7.5K
Citations:
1.6W